BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31848524)

  • 1. [Hypophosphatemic osteomalacia caused by urinary mesenchymal tumor: A case report].
    Wei H; Liu R; Wang ZH; Yao ZQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1169-1172. PubMed ID: 31848524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 4. Reports of 17 Chinese patients with tumor-induced osteomalacia.
    Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
    J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria.
    Velazquez-Navarro JA; Loya-Teruel E; Rios-Gomez M; Montes-Ramirez JE
    Cureus; 2022 Jan; 14(1):e20893. PubMed ID: 35145798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
    Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
    Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
    Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
    Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophosphatemia related to a neuro-endocrine tumor of the pancreas: A case report.
    Pickering ME; Bouvier D; Puravet A; Soubrier M; Sapin V; Oris C
    Clin Biochem; 2022 Jun; 104():62-65. PubMed ID: 35337828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Right Leg that Troubled the Left Leg.
    B S; V A
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of recurrent spinal phosphaturic mesenchymal tumor-induced osteomalacia: A case report.
    Liu S; Zhou X; Song A; Huo Z; Wang Y; Liu Y
    Medicine (Baltimore); 2020 Jan; 99(4):e18603. PubMed ID: 31977851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F; Minisola S; Sgueglia M; Blasi S; Brunelli D; Degli Effetti E; Maturo A; Cola A; Custureri F; Campana FP
    G Chir; 2006; 27(1-2):9-13. PubMed ID: 16608626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of phosphaturic mesenchymal tumor-induced osteomalacia.
    Wu W; Wang C; Ruan J; Chen F; Li N; Chen F
    Medicine (Baltimore); 2017 Dec; 96(51):e9470. PubMed ID: 29390586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of tumor-induced osteomalacia: a single center experience.
    Hacisahinogullari H; Tekin S; Tanrikulu S; Saribeyliler G; Yalin GY; Bilgic B; Isik EG; Salduz A; Tuncer S; Gul N; Uzum AK; Aral F; Tanakol R; Selcukbiricik OS
    Endocrine; 2023 Nov; 82(2):427-434. PubMed ID: 37480497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphaturic mesenchymal tumor-induced bilateral osteomalacia femoral neck fractures: a case report.
    Zhang Y; Hu M; Guo C; Yang X; Xiang S; Xu H
    Front Endocrinol (Lausanne); 2024; 15():1373794. PubMed ID: 38689735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced osteomalacia.
    Florenzano P; Gafni RI; Collins MT
    Bone Rep; 2017 Dec; 7():90-97. PubMed ID: 29021995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM; Schalin-Jäntti C; Matikainen N
    Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor].
    Kin Y; Ogawa H; Matsumoto G; Mitsui S; Matsumoto T; Nishioka Y; Sakai S; Kimura K; Shimizu N; Hokka D; Tanaka Y; Maniwa Y
    Kyobu Geka; 2019 Aug; 72(8):570-573. PubMed ID: 31353346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.